- Home
- FLUX vs CALC Comparison
FLUX vs CALC Comparison
Compare FLUX & CALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLUX
- CALC
- Stock Information
- Founded
- FLUX N/A
- CALC 2011
- Country
- FLUX United States
- CALC United States
- Employees
- FLUX N/A
- CALC N/A
- Industry
- FLUX Industrial Machinery/Components
- CALC Biotechnology: Pharmaceutical Preparations
- Sector
- FLUX Miscellaneous
- CALC Health Care
- Exchange
- FLUX Nasdaq
- CALC Nasdaq
- Market Cap
- FLUX 26.9M
- CALC 22.9M
- IPO Year
- FLUX N/A
- CALC N/A
- Fundamental
- Price
- FLUX $1.97
- CALC $1.61
- Analyst Decision
- FLUX Strong Buy
- CALC Strong Buy
- Analyst Count
- FLUX 2
- CALC 3
- Target Price
- FLUX $6.00
- CALC $16.33
- AVG Volume (30 Days)
- FLUX 74.8K
- CALC 29.8K
- Earning Date
- FLUX 08-15-2025
- CALC 08-11-2025
- Dividend Yield
- FLUX N/A
- CALC N/A
- EPS Growth
- FLUX N/A
- CALC N/A
- EPS
- FLUX N/A
- CALC N/A
- Revenue
- FLUX $63,074,000.00
- CALC N/A
- Revenue This Year
- FLUX $11.10
- CALC N/A
- Revenue Next Year
- FLUX $12.66
- CALC N/A
- P/E Ratio
- FLUX N/A
- CALC N/A
- Revenue Growth
- FLUX N/A
- CALC N/A
- 52 Week Low
- FLUX $1.15
- CALC $1.42
- 52 Week High
- FLUX $4.75
- CALC $5.97
- Technical
- Relative Strength Index (RSI)
- FLUX 64.88
- CALC 46.35
- Support Level
- FLUX $1.36
- CALC $1.42
- Resistance Level
- FLUX $1.60
- CALC $1.85
- Average True Range (ATR)
- FLUX 0.13
- CALC 0.15
- MACD
- FLUX 0.04
- CALC -0.00
- Stochastic Oscillator
- FLUX 91.10
- CALC 41.86
About FLUX Flux Power Holdings Inc.
Flux Power Holdings Inc design, develop, manufacture, and sell a portfolio of lithium-ion energy storage solutions for electrification of a range of industrial commercial sectors which include material handling, airport ground support equipment (GSE), and other commercial and industrial applications. It offers a high-power battery cell management system(BMS). The company's BMS provides three functions to its battery systems which include Cell Balancing, Monitoring, and Error Reporting.
About CALC CalciMedica Inc.
CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.